PillsPharmac
  • Home
Successful Search?
Try one of the below options to narrow down your search.
Google Custom Search:
Loading
PHARMAC Search:

Documents may be browsed by date, eg; Today, May, 2013.

Past years can be browsed too, eg; 2012, 2011, 2010, 2009 ...

Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg; Media releases from 2013

Document tags (shown below the document date, eg; Schedule, SAForms, consultation ...) have highest priority when search results are ranked, followed by title, abstract and full text of document.

Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.

Remember to group or statements with parentheses if they are beside and statements.

Search examples

consultation
Search for consultations
media and not antibiotics
Search for media related documents that don't mention antibiotics.
(media or consultation) and vaccines
Search for media releases and consultation documents mentioning vaccinations.

Search term:

2012

PHARMAC documents that matched your search:

Prev, Next – Page 1 of 31 (307 documents)

icon

Decision to fund tramadol sustained release tablets; Contact: Notifications; Posted: 2012-12-21 (2 pages, 106 KB)
2012/12/21
notification

21 December 2012 Decision to fund tramadol sustained release tablets PHARMAC is pleased to announce the approval of an agreement with CSL Biotherapies NZ Ltd to list tramadol sustained release tablets (Tramal SR) in Section B, and to amend the…

text


icon

Decision to fund Paradigm X22 insulin pump and consumables; Contact: Notifications; Posted: 2012-12-20 (2 pages, 109 KB)
2012/12/20
notification

20 December 2012 Decision to fund Paradigm X22 insulin pump and consumables PHARMAC is pleased to announce the approval of an agreement with Medtronic New Zealand Ltd for the funding of Paradigm X22 insulin pumps and related consumables. This was…

text


icon

2013-01 Schedule Dispatch (4 pages, 113 KB)
2012/12/18
ScheduleDispatch, SchedulePublications

17 December 2012 January 2013 Pharmaceutical Schedule Dispatch This document is provided to pharmacists as an early notification of the changes to be announced in the January 2013 Update to the Pharmaceutical Schedule. Please notify PHARMAC (0800 66 00 50)…

text


icon

Decision to list posaconazole; Contact: Notifications; Posted: 2012-12-18 (2 pages, 111 KB)
2012/12/18
notification

17 December 2012 Decision to list posaconazole PHARMAC is pleased to announce the approval of an agreement with Merck Sharp & Dohme (New Zealand) Limited to list posaconazole (Noxafil) oral suspension. This was the subject of a consultation letter dated…

text


icon

Schedule Update - effective 1 January 2013 (45 pages, 815 KB)
2012/12/18
SchedulePublications, update

Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 January 2013 Cumulative for December 2012 and January 2013 Contents Summary of PHARMAC decisions efffective 1 January 2013 ….. 3 Insulin pumps and consumables – further brand subsidised …. 5…

text


icon

Economic Assessment Guide Explained (11 pages, 240 KB)
2012/12/14

Pharmaceutical Management Agency Cost-Utility Analysis (CUA) Explained Cost-Utility Analysis (CUA) at PHARMAC Questions and Answers go to page 8 >> The process described in this document is intended to be indicative of the process that PHARMAC may use when undertaking…

text


icon

Decision to amend the diphtheria, pertussis and tetanus vaccine (Boostrix) listing; Contact: Notifications; Posted: 2012-12-12 (3 pages, 108 KB)
2012/12/12
notification

12 December 2012 Decision to amend the diphtheria, pertussis and tetanus vaccine (Boostrix) listing PHARMAC is pleased to announce the approval of a proposal to amend the criteria for accessing funding for the combination diphtheria, pertussis and tetanus vaccine (under…

text


icon

Letter of Expectations 2012-2013 (4 pages, 284 KB)
2012/12/12
LetterOfExpectations

text


icon

Proposal to fund sildenafil for the treatment of Raynaud's phenomenon; Closing Date: Closed; Contact: Stephen Woodruffe (2 pages, 113 KB)
2012/12/10
consultation

10 December 2012 Proposal to fund sildenafil for the treatment of Raynaud’s phenomenon PHARMAC is seeking feedback on a proposal to:  Fund sildenafil for patients with Raynaud’s phenomenon who meet the Special Authority eligibility criteria. The proposal does not…

text


icon

PHARMAC lifts restrictions on some cancer treatments (2 pages, 77 KB)
2012/12/07
media

7 December 2012 Media release PHARMAC steps up to help meet Government cancer treatment goal Recent decisions by PHARMAC will have a positive effect on cancer treatment in New Zealand. PHARMAC has removed the Special Authority funding requirements from seven…

text


Prev, Next – Page 1 of 31 (307 documents)

New Zealand GovernmentAbout Us | Contact Us